At the time of writing, Traws Pharma Inc [TRAW] stock is trading at $1.77, up 9.94%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TRAW shares have gain 32.09% over the last week, with a monthly amount drifted -24.03%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Traws Pharma Inc [NASDAQ: TRAW] stock has seen the most recent analyst activity on December 03, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $8. Previously, Ladenburg Thalmann started tracking the stock with Buy rating on March 01, 2022, and set its price target to $7. On May 18, 2021, Guggenheim initiated with a Buy rating and assigned a price target of $4 on the stock. H.C. Wainwright reiterated its Buy rating and increased its price target to $7.50 on March 01, 2018. Maxim Group downgraded its rating to a Hold. H.C. Wainwright started tracking with a Buy rating for this stock on October 09, 2017, and assigned it a price target of $6. In a note dated April 27, 2017, Laidlaw initiated a Buy rating and provided a target price of $10 on this stock.
For the past year, the stock price of Traws Pharma Inc fluctuated between $0.97 and $8.61. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. Traws Pharma Inc [NASDAQ: TRAW] shares were valued at $1.77 at the most recent close of the market. An investor can expect a potential return of 351.98% based on the average TRAW price forecast.
Analyzing the TRAW fundamentals
According to Traws Pharma Inc [NASDAQ:TRAW], the company’s sales were 2.85M for trailing twelve months, which represents an -100.00% plunge. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -3.51%, Pretax Profit Margin comes in at -3.37%, and Net Profit Margin reading is -3.26%. To continue investigating profitability, this company’s Return on Assets is posted at -0.58, Equity is 0.78 and Total Capital is -1.18.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Traws Pharma Inc [NASDAQ:TRAW] has a current ratio of 1.22. Further, the Quick Ratio stands at 1.22, while the Cash Ratio is 1.78. Considering the valuation of this stock, the price to sales ratio is 4.96, the price to book ratio is 2.78 and price to earnings (TTM) ratio is 0.07.
